Loading insider details...
Latest Form 4 (Nov 12, 2026): Grant/Award of 53,000 FLNA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 12, 2026 | FILANA THERAPEUTICS, INC. (FLNA) | Grant/Award | 53,000 | n/a |
| May 5, 2026 | Terns Pharmaceuticals, Inc. (TERN) | Disposition to Issuer | 45,000 | n/a |
| Feb 2, 2026 | Terns Pharmaceuticals, Inc. (TERN) | Grant/Award | 1,697 | n/a |
| Nov 5, 2025 | Terns Pharmaceuticals, Inc. (TERN) | Exercise/Conversion | 24,520 | $226.6K |
| Jun 12, 2025 | Terns Pharmaceuticals, Inc. (TERN) | Grant/Award | 45,000 | n/a |
| Feb 4, 2025 | Terns Pharmaceuticals, Inc. (TERN) | Grant/Award | 10,657 | n/a |
| Jan 7, 2025 | Terns Pharmaceuticals, Inc. (TERN) | Sale | 6,240 | $35.7K |
| Sep 11, 2024 | Terns Pharmaceuticals, Inc. (TERN) | Exercise/Conversion | 17,235 | $31.4K |
| Aug 6, 2024 | Terns Pharmaceuticals, Inc. (TERN) | Sale | 6,143 | $47.1K |
| Jul 17, 2024 | Terns Pharmaceuticals, Inc. (TERN) | Exercise/Conversion | 14,365 | $26.1K |